Douglas MP - Search Results

1

The economic value of personalized medicine tests: what we know and what we need to know.

Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P. Phillips KA, et al. Among authors: douglas mp. Genet Med. 2014 Mar;16(3):251-7. doi: 10.1038/gim.2013.122. Epub 2013 Oct 17. Genet Med. 2014. PMID: 24232413 Free PMC article.

2

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO; EGAPP Working Group. Teutsch SM, et al. Among authors: douglas mp. Genet Med. 2009 Jan;11(1):3-14. doi: 10.1097/GIM.0b013e318184137c. Genet Med. 2009. PMID: 18813139 Free PMC article.

3

Horizon scanning for translational genomic research beyond bench to bedside.

Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ. Clyne M, et al. Among authors: douglas mp. Genet Med. 2014 Jul;16(7):535-8. doi: 10.1038/gim.2013.184. Epub 2014 Jan 9. Genet Med. 2014. PMID: 24406461 Free PMC article.

4

Genomic sequencing: assessing the health care system, policy, and big-data implications.

Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Phillips KA, et al. Among authors: douglas mp. Health Aff (Millwood). 2014 Jul;33(7):1246-53. doi: 10.1377/hlthaff.2014.0020. Health Aff (Millwood). 2014. PMID: 25006153 Free PMC article.

5

Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology.

Garfeld S, Douglas MP, MacDonald KV, Marshall DA, Phillips KA. Garfeld S, et al. Among authors: douglas mp. Per Med. 2015 Jan 1;12(1):13-22. doi: 10.2217/pme.14.74. Per Med. 2015. PMID: 25620993 Free PMC article.

6

Key emerging themes for assessing the cost-effectiveness of reporting incidental findings.

Phillips KA, Ladabaum U, Pletcher MJ, Marshall DA, Douglas MP. Phillips KA, et al. Among authors: douglas mp. Genet Med. 2015 Apr;17(4):314-5. doi: 10.1038/gim.2015.13. Genet Med. 2015. PMID: 25835195 Free PMC article. No abstract available.

7

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.

Douglas MP, Ladabaum U, Pletcher MJ, Marshall DA, Phillips KA. Douglas MP, et al. Genet Med. 2016 Feb;18(2):111-6. doi: 10.1038/gim.2015.69. Epub 2015 May 21. Genet Med. 2016. PMID: 25996638 Free PMC article. Review.

8

Availability and payer coverage of BRCA1/2 tests and gene panels.

Clain E, Trosman JR, Douglas MP, Weldon CB, Phillips KA. Clain E, et al. Among authors: douglas mp. Nat Biotechnol. 2015 Sep;33(9):900-2. doi: 10.1038/nbt.3322. Nat Biotechnol. 2015. PMID: 26348951 Free PMC article. No abstract available.

9

What are people willing to pay for whole-genome sequencing information, and who decides what they receive?

Marshall DA, Gonzalez JM, Johnson FR, MacDonald KV, Pugh A, Douglas MP, Phillips KA. Marshall DA, et al. Among authors: douglas mp. Genet Med. 2016 Dec;18(12):1295-1302. doi: 10.1038/gim.2016.61. Epub 2016 Jun 2. Genet Med. 2016. PMID: 27253734 Free PMC article.

10

Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.

Dervan AP, Deverka PA, Trosman JR, Weldon CB, Douglas MP, Phillips KA. Dervan AP, et al. Among authors: douglas mp. Genet Med. 2017 May;19(5):559-567. doi: 10.1038/gim.2016.145. Epub 2016 Sep 22. Genet Med. 2017. PMID: 27657682 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters